Raymond James & Associates’s ArcBest ARCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,694
Closed -$297K 4028
2022
Q1
$297K Sell
3,694
-1,315
-26% -$119K ﹤0.01% 3421
2021
Q4
$600K Buy
+5,009
New +$510K ﹤0.01% 2952
2017
Q2
Sell
-10,640
Closed -$277K 3339
2017
Q1
$277K Sell
10,640
-4,937
-32% -$145K ﹤0.01% 2736
2016
Q4
$431K Sell
15,577
-1,521
-9% -$39.1K ﹤0.01% 2422
2016
Q3
$325K Buy
+17,098
New +$309K ﹤0.01% 2569
2014
Q2
Sell
-24,527
Closed -$906K 2170
2014
Q1
$906K Buy
24,527
+4,344
+22% +$148K 0.01% 1486
2013
Q4
$680K Sell
20,183
-5,753
-22% -$171K 0.01% 1523
2013
Q3
$666K Buy
+25,936
New +$622K 0.01% 1455

Other funds holding ARCB

Raymond James & Associates's ARCB Position: Q2 2022 in Review

Raymond James & Associates sold out of ArcBest (ARCB) in Q2 2022, closing a stake of 3,694 shares — an estimated $297K sold.

Raymond James & Associates first reported a position in ARCB in Q3 2013 and held it in 8 quarters. The position peaked at $906K in Q1 2014. 250 funds tracked by Wall St. Rank hold ARCB as of Q2 2022.

  • Raymond James & Associates reported no remaining ArcBest position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 3,694 ArcBest shares in Q2 2022, an estimated $297K.
  • Raymond James & Associates first reported a position in ArcBest in Q3 2013 and held it in 8 quarters.
  • Raymond James & Associates's ArcBest position peaked at $906K in Q1 2014.
  • 250 funds tracked by Wall St. Rank held ArcBest as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.